FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro

A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA).

New approvals:
Kerendia cleared for slowing serious kidney, heart complications in type 2 diabetes
Bayer’s Kerendia (finerenone tablets) has been approved for reducing the risk of kidney function decline, kidney failure, cardiovascular death, nonfatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.